101 related articles for article (PubMed ID: 6968775)
21. Antigenic and genetic parameters in the stimulation and in the lytic phases of anti-hapten + self cytotoxic T cells and their derived clones: role of the T helper cell.
Schmitt-Verhulst AM; Albert F; Guimezanes A; Buferne M
J Supramol Struct Cell Biochem; 1981; 16(4):359-70. PubMed ID: 6975828
[TBL] [Abstract][Full Text] [Related]
22. Cellular requirements for induction of human primary proliferative responses to trinitrophenyl-modified cells.
Brown MF; Van M; Abramson SL; Fox EJ; Rich RR
J Immunol; 1984 Jan; 132(1):19-24. PubMed ID: 6228578
[TBL] [Abstract][Full Text] [Related]
23. Clonal analysis of restriction antigens for human TNP-specific cytotoxic T lymphocytes.
Neefe JR; Sullivan JE; Hartzman RJ
J Immunol; 1982 Jan; 128(1):227-32. PubMed ID: 6172479
[TBL] [Abstract][Full Text] [Related]
24. Generation of anti-hapten T cell cytotoxicity in vivo. Relationship to contact sensitivity and the role of contrasuppression.
Ptak W; Friedman AM; Flood PM
Arch Immunol Ther Exp (Warsz); 1994; 42(3):185-92. PubMed ID: 7487350
[TBL] [Abstract][Full Text] [Related]
25. Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells.
Bonnard GD; Yasaka K; Jacobson D
J Immunol; 1979 Dec; 123(6):2704-8. PubMed ID: 315430
[TBL] [Abstract][Full Text] [Related]
26. Human T lymphocyte colonies. I. Surface markers and cytotoxic potential of colony cells.
Klein B; Caraux J; Causse A; Thierry C; Serrou B
Biomedicine; 1981 Feb; 34(1):34-9. PubMed ID: 6971656
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte transformation induced by autologous cells. X. Soluble factors that generate cytotoxic T lymphocytes.
Weksler ME; Moody CE; Ostry RF; Casazza BA
J Exp Med; 1980 Aug; 152(2 Pt 2):284s-291s. PubMed ID: 6447745
[TBL] [Abstract][Full Text] [Related]
28. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.
Lotze MT; Grimm EA; Mazumder A; Strausser JL; Rosenberg SA
Cancer Res; 1981 Nov; 41(11 Pt 1):4420-5. PubMed ID: 6975652
[TBL] [Abstract][Full Text] [Related]
29. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4 T cells induced by trinitrophenylated peptides.
Kohler J; Hartmann U; Grimm R; Pflugfelder U; Weltzien HU
J Immunol; 1997 Jan; 158(2):591-7. PubMed ID: 8992972
[TBL] [Abstract][Full Text] [Related]
30. The requirement of Ia-positive accessory cells for the induction of hapten-reactive cytotoxic T lymphocytes in vitro.
Yamashita U; Hamaoka T
J Immunol; 1979 Dec; 123(6):2637-43. PubMed ID: 315427
[No Abstract] [Full Text] [Related]
31. In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells--a screening predictive assay for contact sensitizers.
Krasteva M; Peguet-Navarro J; Moulon C; Courtellemont P; Redziniak G; Schmitt D
Clin Exp Allergy; 1996 May; 26(5):563-70. PubMed ID: 8735869
[TBL] [Abstract][Full Text] [Related]
32. Evidence for cytotoxic functions in well-defined human T cell clones.
Zagury D; Morgan DA; Fouchard M
Biomedicine; 1980 Dec; 33(8):272-6. PubMed ID: 6971133
[TBL] [Abstract][Full Text] [Related]
33. Structural complexity of antigenic determinants for class I MHC-restricted, hapten-specific T cells. Two qualitatively differing types of H-2Kb-restricted TNP epitopes.
Martin S; von Bonin A; Fessler C; Pflugfelder U; Weltzien HU
J Immunol; 1993 Jul; 151(2):678-87. PubMed ID: 8335903
[TBL] [Abstract][Full Text] [Related]
34. In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cells.
Lotze MT; Strausser JL; Rosenberg SA
J Immunol; 1980 Jun; 124(6):2972-8. PubMed ID: 6989911
[TBL] [Abstract][Full Text] [Related]
35. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
36. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
37. The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness.
Kirk AD; Li RA; Kinch MS; Abernethy KA; Doyle C; Bollinger RR
Transplantation; 1993 Apr; 55(4):924-31. PubMed ID: 8475569
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of the functional activities of human T cells after their interaction with SRBC.
Silva A; Lopez-Botet M; Alvarez J; de Landazuri MO
J Immunol; 1981 Feb; 126(2):393-7. PubMed ID: 6450242
[TBL] [Abstract][Full Text] [Related]
39. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
[TBL] [Abstract][Full Text] [Related]
40. Alloreactive cloned T cell lines. III. Accessory cell requirements for the growth of cloned cytolytic T lymphocytes.
Lutz CT; Glasebrook AL; Fitch FW
J Immunol; 1981 Apr; 126(4):1404-8. PubMed ID: 6970775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
